Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
PRAECIS is also developing an amyloid aggregation inhibitor for the treatment of Alzheimer’s disease and a basic Fibroblast Growth Factor ( bFGF ) antagonist for the treatment of hormonally refractory prostate cancer. ( www.praecis.com )
PRAECIS PHARMACEUTICALS INCORPORATED
830 Winter Street
Waltham, Massachusetts 02451-1420
USA
Tel: (781) 795-4100
Fax: (781) 890-7358